Lumibird: abandoned after its annual sales figures
(CercleFinance.com) - Lumibird dropped 6% after announcing full-year sales of 207.
1 million euros, up 1.7% (+0.1% on a like-for-like basis) in a fiscal year 2024 'contrasted between the two divisions'.
The laser technology specialist reports that annual sales in its medical division rose by 4.8% to 107.7 million euros (+5.4% organic), while sales in its photonics division fell by 1.4% to 99.4 million (-5.4% organic).
The 2024 sales level, while slightly below expectations, enables an EBITDA level close to 16% to be achieved. Lumibird anticipates 'more profitable growth in the coming years, as the fruits of its investments take hold'.
Copyright (c) 2025 CercleFinance.com. All rights reserved.